|
|
|
Volumn 321, Issue 7264, 2000, Pages 833-834
|
|
Effect of drug patents in developing countries [10]
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRETROVIRUS AGENT;
ANTIVIRUS AGENT;
DIDANOSINE;
LAMIVUDINE;
NEVIRAPINE;
STAVUDINE;
ZIDOVUDINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
DEVELOPING COUNTRY;
DRUG COST;
DRUG RESEARCH;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LETTER;
PATENT;
PRIORITY JOURNAL;
VIRUS INFECTION;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
ANTI-HIV AGENTS;
COSTS AND COST ANALYSIS;
DEVELOPING COUNTRIES;
DRUG INDUSTRY;
HUMAN;
PATENTS;
|
|
EID: 0034734859
PISSN: 09598146
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
|
Times cited : (4)
|
|
References (0)
|
